Clinical Study of Propranolol Combined With Neoadjuvant Chemotherapy in Gastric Cancer
Status:
Unknown status
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
At the cellular and animal level, we found that propranolol can inhibit the proliferation and
invasion of gastric cancer cells. Further, we want to explore the efficacy and safety of
propranolol in the treatment of gastric cancer patients.